Build status - In Progress

NCT Update study-4

Investigation of an Investigational Medication for Hypertension

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

TX Study See protocol section 2 See protocol section 2 See protocol section 4

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates hypertension to understand its characteristics and effects. The purpose of this study is to gather information that could help in understanding hypertension better.

The study focuses on evaluating the safety and effectiveness of an investigational medication for hypertension. Researchers aim to gather insights into how the medication interacts with the body.

  • Who can participate: Eligibility criteria include adults aged 18-65 with a diagnosis of hypertension.
  • Study details: Participants will engage in study-related activities as part of the investigation into hypertension and the investigational medication.
Updated on 01 Jul 2025. Study ID: 28782301
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research